In this episode, Hall welcomes Bernard Vogel, Co-founder and Managing Partner at Endeavour Vision.
Endeavour Vision is a leading private equity firm exclusively investing in medical technology. This singular focus requires deep sector knowledge and experience, so their team is made up of industry veterans and investment professionals who are experts in the medtech sector. Their specialties include accelerating company growth and product launches with a proven track record of successful exits.
They invest in growth-stage companies with world-class technology and products. These innovations address an unmet clinical need and hold the potential to significantly improve and extend the lives of patients around the world.
Bernard leads the operational, financial, investor relations, HR, and legal aspects of the firm, and is a board member of several investments, including IntelyCare – a staffing platform for medical personnel. Prior to launching Endeavour in 2000, Bernard worked with McKinsey & Co.
Bernard holds an MBA with distinction from INSEAD in Fontainebleau (France), and an MEng in Mechanical and Industrial Engineering from the Swiss Federal Institute of Technology, Zurich, Switzerland.
Bernard tells Hall what excites him right now, and he advises both entrepreneurs and investors in the space. He discusses the impact COVID-19 has had on the sector and mentions two startups that fit Endeavour Vision’s investment thesis.
You can visit Endeavour Vision at www.endeavourvision.com.
For a full transcript, click here.
Copyright (c) 2021, Hall Martin and investorconnect.org. All rights reserved.
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.